FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to creation of a medicament having pancreatic and hepatoprotective activity, in particular for the treatment of acute pancreatitis and acute hepatitis. Known 2-ethyl-6-methyl-3-oxypyridinium compound L-asparaginate (6-methyl-2-ethylpyridine-3-ol salt of (2S)-2-aminobutanedioic acid) is used as the agent with pancreas and hepatoprotective activity. Also described is a parenteral dosage form based on 2-ethyl-6-methyl-3-oxypyridinium L-asparaginate, formulated as a solution for injection/infusion.
EFFECT: in animals (by lethality and data from biochemical and morphological studies), said compound and dosage form on its basis are superior to closest analogue of the claimed mexidol (in a much larger dose) and other comparators.
2 cl, 7 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DRUG WITH ANTIHYPOXIC, ANTIAMNESTIC AND NEUROPROTECTIVE ACTIVITY | 2020 |
|
RU2750418C1 |
DRUG POSSESSING ACTOPROTECTIVE, ANTIHYPOXIC, NEUROPROTECTIVE, ANTIAMNESTIC AND THERMOPROTECTIVE ACTIVITY | 2011 |
|
RU2460529C1 |
NEUROTROPIC PREPARATION, POSSESSING ANTI-HYPOXIC, NEUROPROTECTIVE, ANTI-AMNESTIC AND VESTIBULAR-PROTECTIVE ACTIVITY | 2014 |
|
RU2547728C1 |
NEUROTROPIC AGENT WITH ANTIOXIDANT, ANTIHYPOXIC, NEUROPROTECTOR, ANTIAMNESIC AND ANTI-MOTION SICKNESS ACTIVITY AND CAPABLE OF ENHANCING COGNITIVE FUNCTIONS | 2008 |
|
RU2394816C1 |
TOOL THAT HAS THE ABILITY TO STIMULATE REPARATIVE PROCESSES OF PERIODONTAL TISSUES, AS WELL AS AN ANTIOXIDANT AND ANTI-INFLAMMATORY EFFECT, WHICH IS A 2-ETHYL-6-METHYL-3-HYDROXYPYRIDIA-2- (3-BENZOILPHENIL)-PROPANOATE, AND A PHARMACEUTICAL COMPOSITION BASED ON IT | 2022 |
|
RU2793537C1 |
PHARMACEUTIC COMPOSITION, POSSESSING ANTIHYPOXIC, NEUROPROTECTIVE AND ANTIAMNESTIC ACTIVITY AND INCREASING PHYSICAL PERFORMANCE CAPACITY | 2010 |
|
RU2425670C1 |
ERGOGENIC PHARMACEUTICAL COMPOSITION EXHIBITING ANTIHPOXIC, NEUROPROTECTIVE AND ANTIAMNESTIC ACTIVITY | 2010 |
|
RU2435605C1 |
PHARMACEUTICAL COMPOSITION OF PANCREATROPIC ACTIVITY AND METHOD OF PHARMACEUTICAL COMPOSITION PRODUCTION | 2007 |
|
RU2341282C2 |
AGENT POSSESSING ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIULCEROGENIC ACTION, ABILITY TO INHIBIT DEVELOPMENT OF DEGENERATIVE-DESTRUCTIVE PROCESSES OF TISSUES, WHICH IS 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM-4-ISOBUTYLPHENYLPROPANOATE | 2023 |
|
RU2814495C1 |
AGENT EXHIBITING HEPATOPROTECTIVE, LIPID-REGULATING, ANTIISCHEMIC AND NEUROTROPIC ACTIVITY | 2018 |
|
RU2705575C1 |
Authors
Dates
2018-07-25—Published
2017-08-15—Filed